Defense Health Agency
Organisation
Awards made
The menopause transition and the gut-brain-axis: an observational study of hormones, microbiota, stress, and mood, HT9425261E470, US$3.1m, 2026–2030, 1 Sept 2026
University of Miami School of Medicine
Bringing alzheimers detection to the front lines evaluating novel cognitive and plasma biomarkers in primary care, HT9425261E260, US$602.8k, 2026–2030, 4 Jun 2026
University of Miami School of Medicine
Bringing alzheimer's detection to the front lines: evaluating novel cognitive and plasma biomarkers in primary care., HT9425261E257, US$1.1m, 2026–2030, 4 Jun 2026
Columbia University Health Sciences
The value of hypertension control to prevent dementia and enhance readiness: generating evidence from dod-vha data, patient preferences and health economics, HT9425261E143, US$301.6k, 2026–2029, 1 May 2026
The value of hypertension control to prevent dementia and enhance readiness: generating evidence from dod-vha data, patient preferences and health economics., HT9425261E142, US$695.3k, 2026–2029, 1 May 2026
Hemoglobin a1c stability and dementia in older adults with diabetes, HT9425261E131, US$997.4k, 2026–2029, 20 Apr 2026
Translating digital wrist tomosynthesis as a novel diagnostic aid to enable osteoporosis screening within the widely accessible mammography setting, HT9425261E066, US$3.3m, 2026–2030, 24 Mar 2026
Biological vs chronological aging: effects on mobility and cognition in multiple sclerosis, HT94252510996, US$319.6k, 2025–2027, 25 Aug 2025
Social determinants of health, biological aging, and disease course in multiple sclerosis, HT94252510920, US$320.2k, 2025–2027, 20 Aug 2025
New York University School of Medicine
The impact of hematopoietic aging on alzheimers disease development, HT94252510757, 2025–2028, 21 Jul 2025
New York University School of Medicine
The impact of hematopoietic aging on alzheimer's disease development, HT94252510758, 2025–2028, 21 Jul 2025
Associations of blood-based neurodegenerative biomarker trajectories with epilepsy, post-traumatic epilepsy, and dementia risk, HT94252510239, US$777.5k, 2025–2028, 2 Jul 2025
Daily patterns and predictors of cognitive function in middle-aged and older adults with neurofibromatosis type 1: an ecological momentary assessment stud, HT94252510362, US$885.5k, 2025–2028, 2 Jul 2025
The aging microenvironment as a driver of pancreatic cancer metastasis, HT94252510657, US$388.2k, 2025–2028, 1 Jul 2025
The aging microenvironment as a driver of pancreatic cancer metastasis, HT94252510664, US$610.1k, 2025–2028, 1 Jul 2025
University of Kansas Medical Center
The biology of frailty in people with multiple sclerosis, HT94252510601, US$250k, 2025–2027, 30 Jun 2025
Delineating the therapeutic effect of a novel bbb-penetrable ppar agonist on chronic outcomes following age-related repetitive mild tbi, HT94252510321, US$3.3m, 2025–2029, 27 May 2025
Alcohol use as a moderating factor in serotonergic neurodegeneration in the early stages of alzheimer's disease, HT94252510432, US$996.6k, 2025–2028, 7 May 2025
Salisbury Foundation for Research and Education
Relationship between blast exposure and cellular senescence in veterans, HT94252510407, US$1.9m, 2025–2029, 6 May 2025
Univ of Massachusetts Med Sch Worcester
Crispr-based adipose therapies for accelerated aging in irradiated nonhuman primates., HT94252510247, US$5.7m, 2025–2028, 3 Apr 2025
Sources: usaspending.gov
Papers
ADA Scientific Sessions 2026 abstract, 6 Jun 2026